Rockefeller Capital Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-6,755
Closed -$695K 1878
2023
Q2
$695K Sell
6,755
-2,280
-25% -$234K ﹤0.01% 1225
2023
Q1
$985K Sell
9,035
-93,069
-91% -$10.1M ﹤0.01% 1089
2022
Q4
$11.6M Buy
102,104
+99,791
+4,314% +$11.4M 0.06% 333
2022
Q3
$143K Sell
2,313
-1,579
-41% -$97.6K ﹤0.01% 1808
2022
Q2
$309K Buy
3,892
+1,789
+85% +$142K ﹤0.01% 1458
2022
Q1
$220K Buy
2,103
+1,759
+511% +$184K ﹤0.01% 1642
2021
Q4
$36K Buy
344
+63
+22% +$6.59K ﹤0.01% 2362
2021
Q3
$29K Sell
281
-609
-68% -$62.9K ﹤0.01% 2422
2021
Q2
$82K Sell
890
-116
-12% -$10.7K ﹤0.01% 1883
2021
Q1
$92K Sell
1,006
-1,521
-60% -$139K ﹤0.01% 1645
2020
Q4
$184K Hold
2,527
﹤0.01% 1224
2020
Q3
$195K Buy
2,527
+1,780
+238% +$137K ﹤0.01% 1050
2020
Q2
$42K Sell
747
-152
-17% -$8.55K ﹤0.01% 1455
2020
Q1
$27K Hold
899
﹤0.01% 1417
2019
Q4
$33K Buy
899
+53
+6% +$1.95K ﹤0.01% 1261
2019
Q3
$23K Sell
846
-57
-6% -$1.55K ﹤0.01% 1188
2019
Q2
$22K Sell
903
-529
-37% -$12.9K ﹤0.01% 1007
2019
Q1
$38K Buy
+1,432
New +$38K ﹤0.01% 1004